Vaccine News and Research

Latest Vaccine News and Research

Partners in health reports on efforts to curb Haiti's cholera epidemic using oral vaccinations

"In April, Partners In Health [PIH] responded to Haiti's cholera epidemic by providing oral vaccinations to 45,000 people living in the country's Artibonite region -- specifically, to two rice-farming communities hit hard by cholera," Louise Ivers, senior health and policy adviser at PIH, reports in an article on the organization's webpage.

3 Aug 2012

Rodent study shows potential for development of more virulent malaria if 'leaky' vaccine used

Using a rodent model to examine the long-term effects of a potential malaria vaccine, a new study published in PLoS Biology by researchers at Penn State University shows that the vaccine could lead to the development of more virulent forms of malaria, the PLoS blog "Biologue" reports.

3 Aug 2012

Australian scientists discover new virus in bats

Australian scientists have discovered a new virus in bats that could help shed light on how Hendra and Nipah viruses cause disease and death in animals and humans. The new virus - named 'Cedar' after the Queensland location where it was discovered - is a close relative of the deadly Hendra and Nipah viruses.

3 Aug 2012

GAVI Alliance announces plans to roll out vaccines in countries isolated by war, secrecy

The New York Times reports on efforts by the GAVI Alliance to deliver vaccines for children in war-torn and secretive countries. According to the newspaper, the non-profit group "sold to North Korea a vaccine against five diseases, and has announced plans to roll out other vaccines soon in Yemen, the Republic of Congo and Pakistan."

2 Aug 2012

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

Scientists have known for some time that throwing off the body's circadian rhythm can negatively affect body chemistry. In fact, workers whose sleep-wake cycles are disrupted by night shifts are more susceptible to chronic inflammatory diseases such as diabetes, obesity and cancer.

2 Aug 2012

People with diabetes, hypertension and hyperlipidemia have difficultly managing all 3 conditions

Most people who have diabetes, high blood pressure, and high cholesterol have difficultly managing all three conditions; indeed, success is fleeting for those who do manage all three, according to a Kaiser Permanente Institute for Health Research study that appears online in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

1 Aug 2012

GSK begins shipping the first lots of 2012-2013 seasonal influenza vaccines

GlaxoSmithKline announced today it has begun shipping the first lots of 2012-2013 FluLaval (Influenza virus vaccine) and Fluarix (Influenza Virus Vaccine) to CDC distribution centers and U.S. healthcare providers.

1 Aug 2012

HIV would 'remain a threat' even if world achieved 'AIDS-free generation' by any definition

Lawrence Altman, former senior medical correspondent for the New York Times, writes in an opinion analysis in the newspaper that while there was much discussion about "ending the AIDS epidemic" and an "AIDS-free generation" at the XIX International AIDS Conference (AIDS 2012) last week in Washington, D.C., "[o]ne obstacle is a failure to clearly define the epidemic or what it means to have an AIDS-free generation."

1 Aug 2012

Poor sleep can reduce effectiveness of vaccines

As moms have always known, a good night's sleep is crucial to good health -- and now a new study led by a UCSF researcher shows that poor sleep can reduce the effectiveness of vaccines.

1 Aug 2012

Guardian's Boseley says USAID's Shah concerned about Europe's commitment to global health issues

In her "Global Health Blog," Guardian health editor Sarah Boseley notes that she spoke with USAID Administrator Rajiv Shah during last week's XIX International AIDS Conference (AIDS 2012).

1 Aug 2012

Australia's top medical researchers for 2012 announced

Finalists for one of Australia’s longest running and most prestigious awards for medical research were announced today. This year’s winner will join a list of alumni winners that includes many of the country’s most respected scientists.

31 Jul 2012

Two new targets could enhance the body's defenses against West Nile and hepatitis C

Two new targets have been discovered for antiviral therapies and vaccines strategies that could enhance the body's defenses against such infectious diseases as West Nile and hepatitis C. The targets are within the infection warning system inside living cells.

31 Jul 2012

Views on AIDS: More funding will be needed for new attack on HIV; The epidemic hits hard in the South

The international AIDS conference in Washington has already made two points clear. There is no prospect that scientists will any time soon find the ultimate solutions to the AIDS epidemic, namely a vaccine that would prevent infection with the AIDS virus or a "cure" for people already infected with the virus.

31 Jul 2012

Infant whooping cough concern

The ongoing increase in whooping cough cases has extended to very young babies, reports the Health Protection Agency, prompting further efforts to step up the immunisation programme.

30 Jul 2012

CNN examines progress, challenges in global polio eradication efforts

"Health efforts are close to wiping out polio, but two significant challenges remain: money and the operational logistics of getting the vaccine to people who need it," CNN writes in an article examining "how far we've come with polio and what's left to be done."

30 Jul 2012

XIX International AIDS Conference concludes in Washington, D.C.

"The XIX International AIDS Conference [AIDS 2012] drew to a close Friday without the physical presence of President Obama but with a full cast of other high-profile U.S. politicians who expressed their commitment to ending the disease," CQ HealthBeat reports (Norman, 7/27).

30 Jul 2012

Biovest receives Rapporteur and Co-Rapporteur designation for BiovaxID personalized cancer vaccine

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has notified Biovest regarding the official designation of the Rapporteur and Co-Rapporteur for BiovaxID, a personalized cancer vaccine for the treatment of follicular non-Hodgkin's lymphoma.

30 Jul 2012

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.

30 Jul 2012

Advaxis reports continued positive patient survival pattern in ADXS-HPV Phase 2 cervical cancer trial

Advaxis, Inc.,, a leader in developing the next generation of immunotherapies for cancer and infectious diseases, presented updated preliminary data from an ongoing randomized Phase 2 trial of ADXS-HPV being conducted in India in women with recurrent/refractory cervical cancer who have failed previous cytotoxic therapy.

30 Jul 2012

UTMB researchers receives NIH grant to develop engineered lung tissue for biomedical studies

University of Texas Medical Branch at Galveston researchers have been awarded a two-year, $1.25 million National Institutes of Health grant to develop a method of custom-growing human lung tissue to make a three-dimensional model for biomedical studies.

30 Jul 2012

Vaccine News and Research

Latest Vaccine News and Research

Partners in health reports on efforts to curb Haiti's cholera epidemic using oral vaccinations

Rodent study shows potential for development of more virulent malaria if 'leaky' vaccine used

Australian scientists discover new virus in bats

GAVI Alliance announces plans to roll out vaccines in countries isolated by war, secrecy

Possible molecular link between circadian rhythm disturbances and increased inflammatory response

People with diabetes, hypertension and hyperlipidemia have difficultly managing all 3 conditions

GSK begins shipping the first lots of 2012-2013 seasonal influenza vaccines

HIV would 'remain a threat' even if world achieved 'AIDS-free generation' by any definition

Poor sleep can reduce effectiveness of vaccines

Guardian's Boseley says USAID's Shah concerned about Europe's commitment to global health issues

Australia's top medical researchers for 2012 announced

Two new targets could enhance the body's defenses against West Nile and hepatitis C

Views on AIDS: More funding will be needed for new attack on HIV; The epidemic hits hard in the South

Infant whooping cough concern

CNN examines progress, challenges in global polio eradication efforts

XIX International AIDS Conference concludes in Washington, D.C.

Biovest receives Rapporteur and Co-Rapporteur designation for BiovaxID personalized cancer vaccine

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Advaxis reports continued positive patient survival pattern in ADXS-HPV Phase 2 cervical cancer trial

UTMB researchers receives NIH grant to develop engineered lung tissue for biomedical studies

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in